Institute of Forensic Medicine, University of Bern, Buehlstrasse 20, 3012, Bern, Switzerland.
Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University Hospital, University of Bern, Freiburgstrasse 8, CH-3010, Bern, Switzerland.
Int J Legal Med. 2019 Nov;133(6):1861-1867. doi: 10.1007/s00414-019-02016-1. Epub 2019 Feb 20.
The goal of this study was to evaluate if unenhanced PMCT HU values of liver pathologies differ from post-mortem HU values of non-pathologic liver tissue.
Liver HU values were measured in five liver segments in PMCT unenhanced datasets of 214 forensic cases (124 male, 90 female, mean age 54.3 years). Liver HU values were compared with corresponding histologic liver findings. HU values of non-pathologic livers were compared to HU values of liver pathologies.
A total of 64 non-pathologic livers (mean HU 58.32, SD 8.91) were assessed. Histologic diagnosed liver pathologies were as follows: steatosis (n = 121 (grade I n = 61, grade II n = 37, grade III n = 23)), fibrosis (n = 10), and cirrhosis (n = 19). HU values of the livers exhibiting severe steatosis (mean HU 32.44, SD 13.76), fibrosis (mean HU 44.7, SD 16.31), and cirrhosis (mean HU 50.59, SD 9.42) significantly differed to HU values of non-pathologic livers at ANOVA testing.
PMCT unenhanced liver HU value measurements may be used as an additional method to detect unspecific liver-pathology. Values below 30 HU may specifically indicate severe steatosis.
本研究旨在评估肝脏病变的未增强 PMCT HU 值与非病变肝组织的死后 HU 值是否存在差异。
在 214 例法医案例的 PMCT 未增强数据集的五个肝段中测量肝脏 HU 值(124 名男性,90 名女性,平均年龄 54.3 岁)。比较了肝脏 HU 值与相应的组织学肝脏发现。比较了非病变肝脏的 HU 值与肝脏病变的 HU 值。
共评估了 64 个非病变肝脏(平均 HU 值 58.32,SD 8.91)。组织学诊断的肝脏病变如下:脂肪变性(n=121(I 级 n=61,II 级 n=37,III 级 n=23))、纤维化(n=10)和肝硬化(n=19)。严重脂肪变性(平均 HU 值 32.44,SD 13.76)、纤维化(平均 HU 值 44.7,SD 16.31)和肝硬化(平均 HU 值 50.59,SD 9.42)的肝脏 HU 值明显与非病变肝脏的 HU 值在 ANOVA 检验中存在差异。
PMCT 未增强肝脏 HU 值测量值可作为检测非特异性肝脏病变的附加方法。低于 30 HU 的值可能特别表明严重的脂肪变性。